Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Neoplasia (New York, N.Y.)
|
December 17, 2013
Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis
Tao Zhang, Junping Zhang, Ming Cui, et al.
Cancer Research
|
March 17, 2016
Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade
Yu Zhao, Hang Li, Yingyi Zhang, et al.
Bioorganic Chemistry
|
November 21, 2024
Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies
Jinwei Zhang, Maoshuo Yang, Qian Liu, et al.
Journal of Medicinal Chemistry
|
March 6, 2026
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency
Qipeng Chai, Maoshuo Yang, Chunxi Liu, et al.
Journal of Medicinal Chemistry
|
April 3, 2025
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation
Maoshuo Yang, Wei Zhao, Jinwei Zhang, et al.
The EMBO Journal
|
September 6, 2021
PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability
Fabao Liu, Min Ma, Ang Gao, et al.
Nature Cell Biology
|
October 24, 2017
PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Fabao Liu, Fengfei Ma, Yuyuan Wang, et al.
Nature Cell Biology
|
November 30, 2017
Erratum: PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Fabao Liu, Fengfei Ma, Yuyuan Wang, et al.
Cancer Letters
|
January 25, 2025
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis
Xiaona You, Xi Hu, Zenghui Sun, et al.
Journal of Medicinal Chemistry
|
December 26, 2025
Utilizing the HiBiT System to Identify CARM1 Degraders for Targeted Cancer Therapy
Megan Bacabac, Mingshan Hu, Fabao Liu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Neoplasia (New York, N.Y.)
|
December 17, 2013
Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis
Tao Zhang, Junping Zhang, Ming Cui, et al.
Cancer Research
|
March 17, 2016
Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade
Yu Zhao, Hang Li, Yingyi Zhang, et al.
Bioorganic Chemistry
|
November 21, 2024
Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies
Jinwei Zhang, Maoshuo Yang, Qian Liu, et al.
Journal of Medicinal Chemistry
|
March 6, 2026
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency
Qipeng Chai, Maoshuo Yang, Chunxi Liu, et al.
Journal of Medicinal Chemistry
|
April 3, 2025
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation
Maoshuo Yang, Wei Zhao, Jinwei Zhang, et al.
The EMBO Journal
|
September 6, 2021
PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability
Fabao Liu, Min Ma, Ang Gao, et al.
Nature Cell Biology
|
October 24, 2017
PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Fabao Liu, Fengfei Ma, Yuyuan Wang, et al.
Nature Cell Biology
|
November 30, 2017
Erratum: PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Fabao Liu, Fengfei Ma, Yuyuan Wang, et al.
Cancer Letters
|
January 25, 2025
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis
Xiaona You, Xi Hu, Zenghui Sun, et al.
Journal of Medicinal Chemistry
|
December 26, 2025
Utilizing the HiBiT System to Identify CARM1 Degraders for Targeted Cancer Therapy
Megan Bacabac, Mingshan Hu, Fabao Liu, et al.
Page
of 4